CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
688091 Shanghai Yizhong Pharmaceutical
- 43.47
- +0.97+2.28%
Market Closed Apr 30 15:00 CST
8.99BMarket Cap-1114.62P/E (TTM)
44.09High42.01Low21.43KlotVolume42.64Open42.50Pre Close92.96MTurnover1.04%Turnover Ratio1278.53P/E (Static)206.70MShares53.1852wk High6.32P/B8.99BFloat Cap20.2752wk Low51.00Limit Up206.70MShs Float101.81Historical High34.00Limit Down4.89%Amplitude19.31Historical Low0.24Dividend TTM43.39Avg Price7.34KlotAsk0.55%Div YieldTTM100Lot Size12.99KlotBid
Shanghai Yizhong Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -26.73%58.48M | 4.46%277.77M | 2.02%199.79M | -1.20%129.76M | 23.11%79.81M | 29.23%265.91M | 36.56%195.83M | 194.32%131.34M | 170.76%64.83M | 51,288.01%205.77M |
| Refunds of taxes and levies | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.52M |
| Cash received relating to other operating activities | -78.54%1.32M | 93.38%4.8M | -49.68%1.96M | -61.94%743.71K | 430.13%6.15M | -78.57%2.48M | 644.05%3.9M | 553.45%1.95M | 36.75%1.16M | 99.25%11.58M |
| Cash inflows from operating activities | -30.43%59.8M | 5.28%282.57M | 1.01%201.75M | -2.09%130.5M | 30.27%85.96M | 20.43%268.39M | 33.65%199.73M | 164.24%133.29M | 117.69%65.99M | 3,488.70%222.86M |
| Goods services cash paid | 958.58%25.79M | -10.81%6.48M | 17.08%4.91M | -26.34%1.92M | 29.99%2.44M | 9.43%7.26M | -18.41%4.19M | 23.80%2.61M | 128.69%1.87M | -71.47%6.64M |
| Staff behalf paid | 21.45%19.68M | 9.54%70.83M | 14.43%44.52M | 26.04%30.32M | 51.62%16.21M | 98.70%64.67M | 116.59%38.9M | 104.88%24.06M | 138.78%10.69M | 72.94%32.54M |
| All taxes paid | -88.02%924.69K | -27.55%23.89M | -20.95%22.15M | 26.85%20.45M | 89.22%7.72M | 610.70%32.97M | 2,167.63%28.02M | 6,986.34%16.12M | 12,140.70%4.08M | 839.57%4.64M |
| Cash paid relating to other operating activities | 59.05%48.86M | 84.47%141.93M | 65.90%109.31M | 110.77%73.03M | 57.48%30.72M | 12.72%76.94M | 153.97%65.89M | 380.01%34.65M | 420.17%19.51M | 449.32%68.26M |
| Cash outflows from operating activities | 66.88%95.26M | 33.71%243.13M | 32.03%180.88M | 62.35%125.72M | 57.90%57.08M | 62.24%181.84M | 172.49%137M | 263.59%77.44M | 298.16%36.15M | 103.80%112.08M |
| Net cash flows from operating activities | -222.80%-35.46M | -54.44%39.44M | -66.74%20.87M | -91.45%4.78M | -3.21%28.88M | -21.87%86.55M | -36.75%62.73M | 91.64%55.85M | 40.52%29.84M | 327.09%110.78M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 596.92%2.27B | ---- | ---- | ---- | --325M | ---- | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | -89.93%244.09K | -43.00%22.39M | 12.55%21.83M | 14.41%17.48M | 21.30%2.42M | 46.20%39.27M | 7.94%19.39M | -0.37%15.28M | -62.43%2M | 329.61%26.86M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | --500 | --10.51K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | 222.98%4.58B | 175.11%2.89B | 56.86%885M | ---- | -53.94%1.42B | -58.11%1.05B | -71.20%564.2M | -68.68%348M | 324.74%3.08B |
| Cash inflows from investing activities | 591.84%2.27B | 215.82%4.6B | 172.16%2.91B | 55.74%902.48M | -6.45%327.42M | -53.08%1.46B | -57.64%1.07B | -70.65%579.48M | -68.65%350M | 324.79%3.11B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -93.74%426.83K | 811.43%80.04M | 506.81%52.64M | 121.55%16.96M | 55.25%6.82M | -75.53%8.78M | -71.81%8.67M | -57.43%7.66M | -67.29%4.39M | 1,041.72%35.88M |
| Cash paid relating to other investing activities | 646.89%2.28B | 253.96%4.72B | 200.55%3.03B | 172.63%1.47B | -5.57%305M | -48.12%1.33B | -49.76%1.01B | -62.52%539.2M | -65.40%323M | 69.67%2.57B |
| Cash outflows from investing activities | 630.70%2.28B | 257.61%4.8B | 203.16%3.08B | 171.91%1.49B | -4.76%311.82M | -48.50%1.34B | -50.10%1.02B | -62.46%546.86M | -65.43%327.39M | 71.69%2.6B |
| Net cash flows from investing activities | -184.45%-13.18M | -265.37%-192.65M | -414.22%-168.8M | -1,891.54%-584.48M | -30.96%15.61M | -76.81%116.49M | -89.02%53.72M | -93.70%32.62M | -86.66%22.61M | 163.93%502.27M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --2.59M | --18.77M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | ---- | -79.32%9.1M | -54.73%9.1M | --9.1M | --9.1M | --44M | --20.1M | ---- | ---- | ---- |
| Cash inflows from financing activities | -71.55%2.59M | -36.66%27.87M | -54.73%9.1M | --9.1M | --9.1M | --44M | --20.1M | ---- | ---- | ---- |
| Borrowing repayment | ---- | --53.1M | --42.2M | --22.1M | ---- | ---- | ---- | ---- | ---- | 415.38%16.75M |
| Dividend interest payment | ---- | 14.71%49.79M | 14.77%49.79M | 14.74%49.67M | --294.6K | 8,733.14%43.41M | 30,989.11%43.38M | 30,920.72%43.29M | ---- | -16.55%491.43K |
| Cash payments relating to other financing activities | ---- | --37.24M | --27.94M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from financing activities | ---- | 222.83%140.14M | 176.44%119.92M | 65.80%71.77M | --294.6K | 151.77%43.41M | 156.85%43.38M | 156.29%43.29M | ---- | -78.41%17.24M |
| Net cash flows from financing activities | -70.60%2.59M | -19,073.50%-112.27M | -376.02%-110.82M | -44.78%-62.67M | --8.81M | 103.43%591.7K | -37.84%-23.28M | -156.29%-43.29M | ---- | -101.83%-17.24M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | -186.42%-46.06M | -230.37%-265.48M | -377.74%-258.76M | -1,521.40%-642.37M | 1.62%53.29M | -65.82%203.64M | -83.70%93.17M | -91.48%45.19M | -70.15%52.44M | 440.48%595.82M |
| Add:Begin period cash and cash equivalents | -29.18%644.41M | 28.83%909.89M | 28.83%909.89M | 28.83%909.89M | 28.83%909.89M | 539.54%706.25M | 539.54%706.25M | 539.54%706.25M | 539.54%706.25M | 57,572.51%110.43M |
| End period cash equivalent | -37.88%598.35M | -29.18%644.41M | -18.55%651.13M | -64.40%267.51M | 26.95%963.18M | 28.83%909.89M | 17.21%799.41M | 17.30%751.44M | 165.17%758.69M | 539.54%706.25M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | -- | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.